Hormonal, syndromal and EEG mapping studies in menopausal syndrome patients with and without depression as compared with controls

Maturitas

Volumn 23, Issue 1, 1996, Pages 91-105

  Saletu, Bernd ^a   Brandstätter, Nadja ^a   Metka, Markus ^a   Stamenkovic, Mara ^a   Anderer, Peter ^a   Semlitsch, Heribert V ^a   Heytmanek, G ^a   Huber, J ^a   Grünberger, Josef ^a   Linzmayer, Leopold ^a   Kurz, Ch ^a   Decker, Kathrin ^a   Binder, Gertrude ^a   Knogler, W ^a   Koll, B ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Asymmetry index; EEG mapping; Frontal lobe dysfunction; FSH; Hamilton depression score; Kupperman index; Major depression; Menopausal syndrome; Oestrogen

Indexed keywords

ESTRADIOL; FOLLITROPIN;

ADULT; ALERTNESS; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DEPRESSION; ELECTROENCEPHALOGRAM; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; SYMPTOMATOLOGY;

EID: 17044451505     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(95)00946-9     Document Type: Article

References (76)

1. Hunter M, Battersby R, Whitehead M. Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas 1986; 8: 217-228.
2. Hutton JD, Jacobs HS, James VHT. Steroid endocrinology after the menopause - a review. J R Soc Med 1979; 72: 835-841.
3. Thompson J, Oswald I. Effect of estrogen on the sleep, mood and anxiety of menopausal women. Br Med J 1977; 2: 1317-1319.
4. Hunter MS. Emotional well-being, sexual behaviour and hormone replacement therapy. Maturitas 1990; 12: 299-314.
5. Coope J. 1st oestrogen therapy effective in the treatment of menopausal depression? J R Coll Gen Pract 1981; 31: 134-140.
6. Ballinger CB, Browning MCK, Smith AHW. Hormone profiles and psychological symptoms in perimenopausal women. Maturitas 1987; 9: 235-251.
7. Utian WH. Definitive symptoms of post-menopause incorporating use of vaginal parabasal cell index. In: Van Keep PA, Lauritzen C, eds. Frontiers in hormone research: oestrogens in the post-menopause, Basel: Karger, 1975.
8. Sherwin BB, Gelfand MM. Sex steroids and affect in the surgical menopause: a double-blind, cross-over study. Psychoneuroendocrinology 1985; 10: 325-335.
9. Dennerstein L, Burrows GD, Hyman C, Sharpe K. Hormone therapy and affect. Maturitas 1979; 1: 247-259.
10. Coope J, Thomson J, Poller L. Effects of natural oestrogen replacement therapy on menopausal symptoms and blood clotting. Br Med J 1975; 4: 139-143.
11. George GCW, Beaumont PJV, Beardwood CJ. Effects of exogenous oestrogens on minor psychiatric symptoms in postmenopausal women. S Afr Med J 1973; 47: 2387-2394.
12. Stickler RC. The role of oestrogen replacement in the climacteric syndrome. Psychol Med 1977; 7: 631-637.
13. Durst N, Maoz B. Changes in psychological well-being during postmenopause as a result of oestrogen therapy. Maturitas 1979; 1: 301-315.
14. Campbell S. Double blind psychometric studies on the effects of natural oestrogens on postmenopausal women. In: Campbell S, ed. The management of the menopause and postmenopausal years, Lancaster: MTP Press, 1976.
15. Gerdes LC, Sonnendecker EWW, Polakow ES. Psychological changes effects by oestrogen - progestogen and clonidine treatment in climacteric women. Am J Obs Gynaecol 1982; 142: 98-104.
16. Klaiber EL, Broverman DM, Vogel W, Korbayasti V. Oestrogen therapy for severe persistent depression in women. Arch Gen Psychiatry 1979; 36: 550-554.
17. Montgomery JC, Appelby L, Brincat M, Versi E, Tapp A, Fenwick PBC, Studd JWW. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987; Feb.7: 297-299.
18. Duffy FH, Albert MS, McAnulty G. Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type. Ann Neurol 1984; 16: 439-448.
19. Itil TM, Shapiro DM, Eralp E, Akmann A, Itil KZ, Garbizu C. A new brain function diagnostic unit, including the dynamic brain mapping of computer analyzed EEG, evoked potentials and sleep (a new hardware/software system and its application in psychiatry and psychopharmacology). New Trends Exp Clin Psychiatr 1985; 1: 107-177.
20. Saletu B, Anderer P, Kinsperger K, Grün berger J. Topographic brain mapping of EEG in neuropsychopharmacology - part II. Clinical applications (Pharmaco EEG imaging). Meth Find Exp Clin Pharmacol 1987; 9 (6): 385-408.
21. Saletu B. Neurophysiological and psychometric evaluation of central effects of classic and novel antidepressants. EEG mapping in depression. In: Mendlewicz J, Brunello N, Langer SZ, Racagni G, eds. New Pharmacological Approaches to the Therapy of Depressive Disorders. International Academy for Biomedical and Drug Research, Vol. 5, Basel, Paris, London, New York, Singapore, Tokyo, Syndney: Karger, 1993; 48-61.
22. Saletu B. EEG/EP mapping in neurodegenerative and cognitive disorders. In: Racagni G, Brunello N, Langer SZ, eds. Recent Advances in the Treatment of Neurodegenerative Disorders and Cognitive Dysfunction, Basel, Freiburg, Paris, London, New York, New Delhi, Bangkok, Singapore, Tokyo,: Karger, 1994; 24-30.
23. John ER, Prichep LS, Fridman J, Easton P. Neurometrics: Computer assisted differential diagnosis of brain dysfunctions. Science 1988; 239: 162-169.
24. Schaffer CE, Davidson RJ, Saron C. Frontal and parietal electroencephalogram asymmetry in depressed and non-depressed subjects. Biological Psychiatry 1983; 18: 753-762.
25. Davidson RJ. Hemispheric asymmetry and emotion. In: Scherer K, Ekman P. eds. Approaches to emotion, Hillsdale, NJ: Erlbaum, 1984; 39-57.
26. Davidson RJ. Cerebral asymmetry and the nature of emotion: Implications for the study of individual differences and psychopathology. In: Takahashi R, Flor-Henry P, Gruzelier J, Niwa S, eds. Cerebral dynamics, laterality and psychopathology, New York: Elsevier Science Publishers, 1987; 71-83.
27. Henriques JB, Davidson RJ. Regional brain electrical asymmetries discriminate between previously depress and healthy control subjects. J Abnormal Psychol 1990; 99(1): 22-31.
28. Henriques JB, Davidson RJ. Left frontal hypoactivation in depression. J Abnormal Psychol 1991; 100(4): 535-545.
29. Saletu B, Brandstätter N, Metka M, Stamenkovic M, Anderer P, Semlitsch HV, Heytmanek G, Huber J, Grünberger J, Linzmayer L, Kurz Ch, Decker K, Binder G. Knogler W, Koll B. Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal estradiol therapy in menopausal depression. Psychopharmacology, 1995; 122: 321-329.
30. Hormone Laboratory, I. Universitäts-Frauenklinik. Normalwerte. 1989.
31. Kupperman HS. Contemporary therapy of the menopausal syndrome. JAMA 1959; 171(12): 1627-1637.
32. American Psychiatric Association. Diagnostisches und statistisches Manual psychischer Störungen DSM-III-R. American Psychiatric Association, 1989.
33. Berner P. Vienna research criteria. In: Berner P, Gabriel E, Katschnig H, Kieffer W, Koehler K, Lenz G, Simhandl Ch, eds. Diagnostic criteria for schizophrenic and affective psychoses, World Psychiatr Assoc, 1983; 157-163.
34. AMDP Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie. . Das AMDP-System. Manual zur Dokumentation psychiatrischer Befunde, 4. Auflage. Berlin, Heidelberg, New York: 1981.
35. Janke W, Debus G. Die Eigenschaftswörterliste EWL. Göttingen, Toronto, Zürich: Verlag für Psychologie, Dr. C.J. Hogrefe, 1978.
36. Hamilton M. HAMD Hamilton Depression Scale. In: CIPS, ed. Internat. Skalen für Psychiatrie, Weinheim: Beltz Test GmbH, 1986.
37. Anderer P, Salelu B, Kinsperger K, Semlitsch H. Topographic brain mapping of EEG in neuropsychopharmacology - part I. Methodological aspects. Meth Find Exp Clin Pharmacol 1987; 9 (6): 371-384.
38. Anderer P, Semlitsch HV, Saletu B, Barbanoj MJ. Artifact processing in topographic mapping of electroencephalographic activity in neuropsychopharmacology. Psychiatry Res 1992; 45: 79-93.
39. Bartels PH, Subach JA. Automated interpretation of complex scenes. In; Preston E, Onoe M, eds. Digital Processing of Biomedical Imagery, New York: Academic Press, 1976; 101-114.
40. Duffy FH, Bartels PH, Burchfield JE. Significance probability mapping: An aid in the topographic analysis of brain electrical activity. Electroencephalogr Clin Neurophysiol 1981; 51: 455-462.
41. Doyle JC, Ornstein R, Galen D. Lateral specialization of cognitive mode: II EEG frequency analysis. Psychophysiology 1974; II: 567-577.
42. Gasser T, Sroka E, Mocks O. The transfer of EOG activity into the EEG for eyes open and eyes closed. Electroencephalogr Clin Neurophys 1985; 61: 181-193.
43. Gasser T, Bäcker P, Steinberg H. Test-retest reliability of spectral parameters of the EEG. Electroencephalogr Clin Neurophys 1985; 61: 181-193.
44. George SL. The required size and length of a phase III clinical trial. In: Buyse, Staquet, Sylvester, eds. Cancer clinical trials, Oxford: Oxford Medical Publications, 1988.
45. Abt K. Descriptive data analysis (DDA) in quantitative EEG studies. In: Samson-Dollfus D, Guieu JD, Gotman J, Etevenon P, eds. Statistics and topography in quantitative EEG, Amsterdam: Elsevier, 1988; 150-160.
46. Hunter M. The South-East England longitudinal study of the climacteric and postmenopause. Maturitas 1992; 14: 117-126.
47. Head H. The conception of nervous and mental energy. 11. Vigilance: a physiological state of the nervous system. Br J Psychol 1923; 14: 125-147.
48. Perini G, Mendius R. Depression and anxiety in complex partial seizures. J Nerv Mental Dis 1984; 172: 287-290.
49. Gainotti G. Emotional behaviour and hemispheric side of the lesion. Cortex 1972; 8: 41-55.
50. Sackheim HA, Greenberg MS, Weiman AE, Gur R, Hungerbuhler JP, Geschwind N. Hemispheric asymmetry in the expression of positive and negative emotions. Arch Neurol 1982; 39: 210-218.
51. Black FW. Unilateral brain lesions and MMPO performance: A preliminary study. Perceptual Motor Skills 1975; 40: 87-93.
52. Gasparrini WG, Satz P, Heilman KM, Coolidge FE. Hemispheric asymmetries of affective processing as determined by the Minnesota Multiphasic Personality Inventory. J Neurol, Neurosurg Psychiatr 1978; 41: 470-473.
53. Robinson RG, Kubos KE, Starr EB, Rao K, Price TR. Mood disorders in stroke patients. Brain 1984; 107: 81 93.
54. d'Elia G, Perris C. Cerebral functional dominance and depression. Acta Psychiatr Scand 1973; 49: 191-197.
55. d'Elia G, Perris C. Cerebral functional dominance and memory functions. Acta Psychiatr Scand 1974; Suppl.255: 143-157.
56. Matousek M, Capone C, Okawa M. Measurement of the inter-hemispheral differences as a diagnostic tool in psychiatry. Adv Biol Psychiatr 1981; 6: 76-80.
57. Matousek M. EEG patterns in various subgroups of endogenous depression. Int J Psychophysiol 1991; 10: 239-243.
58. Davidson RJ, Tomarken AJ. Laterality and emotion: An electrophysiological approach. In: Boller F, Grafman J, eds. Handbook of Neuropsychology, Amsterdam: Elsevier, 1989; 419-441.
59. Luria AR. The working brain. New York: Basic Books. 1993.
60. Semlitsch HV, Anderer P, Saletu B, Metka M, Brandstätter N, Binder GA, Decker KA. Topographic analysis of event-related potentials (P300) in depressed and non-depressed menopausal syndrome patients. J Neurol 1994; 241: 189.
61. Kuhl DE, Metter EJ, Riege WH. Patterns of cerebral glucose utilization in depression, multiple infarct dementia and Alzheimer's disease. In: Sokoloff L, ed. Brain imaging and brain function. New York: Raven Press, 1985; 211-226.
62. Baxter LR, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, Sumida RM. Cerebral metabolic rates for glucose in mood disorders. Arch Gen Psychiatry 1985; 42: 441-447.
63. Baxter LR, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatr 1989; 46: 243 250.
64. Martinot J-L, Harey P, Feline A, Huret J-D, Mazoyer B, Attar-Levy D, Pappata S, Syrota A. Left prefrontal glucose hypometabolism in the depressed state: A confirmation. Am J Psychiatr 1990; 147: 1313-1317.
65. Guenther W, Moser E, Mueller-Spahn F, von Oefele K, Buelle U, Hippius H. Pathological cerebral blood flow during motor function in schizophrenic and endogenous depressed patients. Biol Psychiatr 1986; 21: 889-899.
66. Asso D. The real menstrual cycle. Avon: Wiley & Son, 1983.
67. Backstrom J. Oestrogen & progesterone in relation to different activities in the central nervous system. Acta Obs Gynaecol Scand 1977; 66: 1.
68. Klaiber EL, Broverman DM, Vogel W. The effects of oestrogen therapy onplasma MAO activity and EEG driving responses of depressed women. Am J Psychiatr 1972; 128: 1429-1498.
69. Aylward M, Maddock J. Plasma tryptophan levels in depression. Lancet 1973; 936.
70. Aylward M. Oestrogens, plasma tryptophan levels in peri-menopausal patients. In: Campbell S, ed. The management of the menopause and post menopausal years, Baltimore: University Park Press, 1976.
71. Gonzales GF, Carrillo C. Blood serotonin levels in postmenopausal women: effects of age and serum oestradiol levels. Maturitas 1993; 17: 23-29.
72. Kaplan R, Mann J. Altered platelet serotonin uptake kinetics in schizophrenia and depression. Life Sci 1982; 31: 583.
73. Guicheney P, Leger D, Barrat J, Trevoux R, De Ligniere B, Roques P, Garnier JP, Boyer P, Grenier J, Dreux C. Platelet serotonin content and plasma tryptophan in periand postmenopausal women: variations with plasma oestrogen levels and depressive symptoms. Eur J Clin Invest 1988; 18: 297 304.
74. Halbreich U, Rojansky N. Palter S, Tworek H, Hissin P, Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 1995; 37: 434-441.
75. Kaufert PA, Gilbert P, Tate R. The Manitoba Project: a re-examination of the link between menopause and depression. Maturitas 1992; 14: 143-155.
76. Brandstätter N, Saletu B, Metka M, Grunberger J, Stamenkovic M, Huber J. Clinical and psychometric studies in menopausal syndrome patients with and without depression. Poster presented at the 5th Annual Meeting of the North American Menopause Society, Washington, D.C., 22nd-24th September, 1994.